Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer

NCT03658434 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT03658434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03658434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Palliative Radiotherapy to Dominant Symptomatic Lesion in Patients With Hormone Refractory Prostate Cancer
Lead sponsor
Zealand University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2018
Completion date
August 1, 2020
Enrollment
34 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hormone-refractory prostate cancer